RTTNews | Oct 12, 2021 10:58AM EDT

10:57 Tuesday, October 12, 2021 (RTTNews.com) - Shares of clinical-stage precision medicine company Relay Therapeutics, Inc. (RLAY) are down 4 percent on Tuesday's trading after the company announced an underwritten public offering of $350 million of shares of its common stock.

The company intends to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the share is of common stock offered in the public offering. All of the shares are to be sold by Relay Therapeutics itself.

Currently at $27.47, the stock has traded between $25.72 and $64.37 during the past 52 weeks.

Read the original article on RTTNews ( https://www.rttnews.com/3232126/relay-therapeutics-down-4-sets-public-offering-of-shares.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved